Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16098417rdf:typepubmed:Citationlld:pubmed
pubmed-article:16098417lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:16098417lifeskim:mentionsumls-concept:C0242698lld:lifeskim
pubmed-article:16098417lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:16098417lifeskim:mentionsumls-concept:C0205082lld:lifeskim
pubmed-article:16098417lifeskim:mentionsumls-concept:C0581603lld:lifeskim
pubmed-article:16098417pubmed:issue4lld:pubmed
pubmed-article:16098417pubmed:dateCreated2005-8-15lld:pubmed
pubmed-article:16098417pubmed:abstractTextRevascularization is a treatment option for moderate-to-severe ischemic cardiomyopathy. Limitations of the current literature, lack of completed randomized trials, and higher periprocedural risks create significant uncertainty about the optimal treatment strategy. This review focuses on the available literature describing the effect of revascularization on outcome and the role of noninvasive viability testing. It attempts to identify a subset of patients likely to benefit from therapy.lld:pubmed
pubmed-article:16098417pubmed:languageenglld:pubmed
pubmed-article:16098417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16098417pubmed:citationSubsetAIMlld:pubmed
pubmed-article:16098417pubmed:statusMEDLINElld:pubmed
pubmed-article:16098417pubmed:monthAuglld:pubmed
pubmed-article:16098417pubmed:issn0735-1097lld:pubmed
pubmed-article:16098417pubmed:authorpubmed-author:GibbonsRaymon...lld:pubmed
pubmed-article:16098417pubmed:authorpubmed-author:GershBernard...lld:pubmed
pubmed-article:16098417pubmed:authorpubmed-author:AraozPhilip...lld:pubmed
pubmed-article:16098417pubmed:authorpubmed-author:Chareonthaita...lld:pubmed
pubmed-article:16098417pubmed:issnTypePrintlld:pubmed
pubmed-article:16098417pubmed:day16lld:pubmed
pubmed-article:16098417pubmed:volume46lld:pubmed
pubmed-article:16098417pubmed:ownerNLMlld:pubmed
pubmed-article:16098417pubmed:authorsCompleteYlld:pubmed
pubmed-article:16098417pubmed:pagination567-74lld:pubmed
pubmed-article:16098417pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:meshHeadingpubmed-meshheading:16098417...lld:pubmed
pubmed-article:16098417pubmed:year2005lld:pubmed
pubmed-article:16098417pubmed:articleTitleRevascularization in severe left ventricular dysfunction: the role of viability testing.lld:pubmed
pubmed-article:16098417pubmed:affiliationDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota 55905, USA. chareonthaitawee.panithaya@mayo.edulld:pubmed
pubmed-article:16098417pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16098417pubmed:publicationTypeReviewlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16098417lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16098417lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16098417lld:pubmed